메뉴 건너뛰기




Volumn 102, Issue 8, 2010, Pages 988-995

Role of intra-arterial hepatic chemotherapy in the treatment of colorectal cancer metastases

Author keywords

liver metastases; metastatic colorectal cancer; regional liver therapy

Indexed keywords

CAPECITABINE; DEXAMETHASONE; FLOXURIDINE; FLUOROURACIL; IRINOTECAN; MITOMYCIN C; NITROSOUREA DERIVATIVE; OXALIPLATIN;

EID: 78650656153     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21753     Document Type: Review
Times cited : (44)

References (61)
  • 1
    • 0033504042 scopus 로고    scopus 로고
    • Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases
    • discussion 318-321.
    • Fong Y, Fortner J, Sun RL, et al.: Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases. Ann Surg 1999; 230: 309-318; discussion 318-321.
    • (1999) Ann Surg , vol.230 , pp. 309-318
    • Fong, Y.1    Fortner, J.2    Sun, R.L.3
  • 2
    • 37549016003 scopus 로고    scopus 로고
    • Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: A multifactorial model of 929 patients
    • Rees M, Tekkis PP, Welsh FK, et al.: Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: A multifactorial model of 929 patients. Ann Surg 2008; 247: 125-135.
    • (2008) Ann Surg , vol.247 , pp. 125-135
    • Rees, M.1    Tekkis, P.P.2    Welsh, F.K.3
  • 3
    • 1342290189 scopus 로고    scopus 로고
    • FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: A randomized GERCOR study
    • Tournigand C, Andre T, Achille E, et al.: FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: A randomized GERCOR study. J Clin Oncol 2004; 22: 229-237.
    • (2004) J Clin Oncol , vol.22 , pp. 229-237
    • Tournigand, C.1    Andre, T.2    Achille, E.3
  • 4
    • 0036104072 scopus 로고    scopus 로고
    • Trends in long-term survival following liver resection for hepatic colorectal metastases
    • Choti MA, Sitzmann JV, Tiburi MF, et al.: Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 2002; 235: 759-766.
    • (2002) Ann Surg , vol.235 , pp. 759-766
    • Choti, M.A.1    Sitzmann, J.V.2    Tiburi, M.F.3
  • 5
    • 33748931490 scopus 로고    scopus 로고
    • Improving resectability of hepatic colorectal metastases: Expert consensus statement
    • Abdalla EK, Adam R, Bilchik AJ, et al.: Improving resectability of hepatic colorectal metastases: Expert consensus statement. Ann Surg Oncol 2006; 13: 1271-1280.
    • (2006) Ann Surg Oncol , vol.13 , pp. 1271-1280
    • Abdalla, E.K.1    Adam, R.2    Bilchik, A.J.3
  • 6
    • 78651054955 scopus 로고
    • The blood supply of neoplasms in the liver
    • Breedis C, Young G,: The blood supply of neoplasms in the liver. Am J Pathol 1954; 30: 969-977.
    • (1954) Am J Pathol , vol.30 , pp. 969-977
    • Breedis, C.1    Young, G.2
  • 7
    • 0016371194 scopus 로고
    • The blood supply of experimental liver metastases. IV. Changes in vascularity with increasing tumor growth
    • Ackerman NB,: The blood supply of experimental liver metastases. IV. Changes in vascularity with increasing tumor growth. Surgery 1974; 75: 589-596.
    • (1974) Surgery , vol.75 , pp. 589-596
    • Ackerman, N.B.1
  • 8
    • 0020552807 scopus 로고
    • Clinical pharmacology of hepatic arterial chemotherapy
    • Ensminger WD, Gyves JW,: Clinical pharmacology of hepatic arterial chemotherapy. Semin Oncol 1983; 10: 176-182.
    • (1983) Semin Oncol , vol.10 , pp. 176-182
    • Ensminger, W.D.1    Gyves, J.W.2
  • 9
    • 0033619892 scopus 로고    scopus 로고
    • Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer
    • Kemeny N, Huang Y, Cohen AM, et al.: Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 1999; 341: 2039-2048.
    • (1999) N Engl J Med , vol.341 , pp. 2039-2048
    • Kemeny, N.1    Huang, Y.2    Cohen, A.M.3
  • 10
    • 0002745494 scopus 로고    scopus 로고
    • Arterial devices for regional hepatic chemotherapy: Transaxillary versus laparotomic access
    • Arru M, Aldrighetti L, Gremmo F, et al.: Arterial devices for regional hepatic chemotherapy: Transaxillary versus laparotomic access. J Vasc Access 2000; 1: 93-99.
    • (2000) J Vasc Access , vol.1 , pp. 93-99
    • Arru, M.1    Aldrighetti, L.2    Gremmo, F.3
  • 11
    • 70350173300 scopus 로고    scopus 로고
    • Anatomic variations of the hepatic arteries in 250 patients studied with 64-row CT angiography
    • De Cecco C, Ferrari R, Rengo M, et al.: Anatomic variations of the hepatic arteries in 250 patients studied with 64-row CT angiography. Eur Radiol 2009; 19: 2765-2770.
    • (2009) Eur Radiol , vol.19 , pp. 2765-2770
    • De Cecco, C.1    Ferrari, R.2    Rengo, M.3
  • 12
    • 33645740453 scopus 로고    scopus 로고
    • Laparoscopic hepatic artery catheterization for regional chemotherapy: Is this the best current option for liver metastatic disease?
    • Franklin M, Trevino J, Hernandez-Oaknin H, et al.: Laparoscopic hepatic artery catheterization for regional chemotherapy: Is this the best current option for liver metastatic disease? Surg Endosc 2006; 20: 554-558.
    • (2006) Surg Endosc , vol.20 , pp. 554-558
    • Franklin, M.1    Trevino, J.2    Hernandez-Oaknin, H.3
  • 13
    • 4043131513 scopus 로고    scopus 로고
    • Laparoscopic placement of hepatic artery infusion pumps: Technical considerations and early results
    • Cheng J, Hong D, Zhu G, et al.: Laparoscopic placement of hepatic artery infusion pumps: Technical considerations and early results. Ann Surg Oncol 2004; 11: 589-597.
    • (2004) Ann Surg Oncol , vol.11 , pp. 589-597
    • Cheng, J.1    Hong, D.2    Zhu, G.3
  • 14
    • 39049118815 scopus 로고    scopus 로고
    • Robotic-assisted placement of a hepatic artery infusion catheter for regional chemotherapy
    • Hellan M, Pigazzi A,: Robotic-assisted placement of a hepatic artery infusion catheter for regional chemotherapy. Surg Endosc 2008; 22: 548-551.
    • (2008) Surg Endosc , vol.22 , pp. 548-551
    • Hellan, M.1    Pigazzi, A.2
  • 15
    • 0021135381 scopus 로고
    • Long-term hepatic arterial infusion chemotherapy. Anatomic considerations, operative technique, and treatment morbidity
    • Daly JM, Kemeny N, Oderman P, et al.: Long-term hepatic arterial infusion chemotherapy. Anatomic considerations, operative technique, and treatment morbidity. Arch Surg 1984; 119: 936-941.
    • (1984) Arch Surg , vol.119 , pp. 936-941
    • Daly, J.M.1    Kemeny, N.2    Oderman, P.3
  • 16
    • 0027504513 scopus 로고
    • Technical considerations and complications associated with the placement of 180 implantable hepatic arterial infusion devices
    • Curley SA, Chase JL, Roh MS, et al.: Technical considerations and complications associated with the placement of 180 implantable hepatic arterial infusion devices. Surgery 1993; 114: 928-935.
    • (1993) Surgery , vol.114 , pp. 928-935
    • Curley, S.A.1    Chase, J.L.2    Roh, M.S.3
  • 17
    • 0037270453 scopus 로고    scopus 로고
    • Technical complications of continuous intra-arterial chemotherapy with 5-fluorodeoxyuridine and 5-fluorouracil for colorectal liver metastases
    • Heinrich S, Petrowsky H, Schwinnen I, et al.: Technical complications of continuous intra-arterial chemotherapy with 5-fluorodeoxyuridine and 5-fluorouracil for colorectal liver metastases. Surgery 2003; 133: 40-48.
    • (2003) Surgery , vol.133 , pp. 40-48
    • Heinrich, S.1    Petrowsky, H.2    Schwinnen, I.3
  • 18
    • 0027214877 scopus 로고
    • Regional chemotherapy devices: Effect of experience and anatomy on complications
    • Campbell KA, Burns RC, Sitzmann JV, et al.: Regional chemotherapy devices: Effect of experience and anatomy on complications. J Clin Oncol 1993; 11: 822-826.
    • (1993) J Clin Oncol , vol.11 , pp. 822-826
    • Campbell, K.A.1    Burns, R.C.2    Sitzmann, J.V.3
  • 19
    • 20544466137 scopus 로고    scopus 로고
    • Technical complications and durability of hepatic artery infusion pumps for unresectable colorectal liver metastases: An institutional experience of 544 consecutive cases
    • Allen PJ, Nissan A, Picon AI, et al.: Technical complications and durability of hepatic artery infusion pumps for unresectable colorectal liver metastases: An institutional experience of 544 consecutive cases. J Am Coll Surg 2005; 201: 57-65.
    • (2005) J Am Coll Surg , vol.201 , pp. 57-65
    • Allen, P.J.1    Nissan, A.2    Picon, A.I.3
  • 20
    • 0022988378 scopus 로고    scopus 로고
    • Directory of on-going research in cancer epidemiology. 1986
    • Muir CS, Wagner G, Demaret E, et al.: Directory of on-going research in cancer epidemiology. 1986. IARC Sci Publ 1986: 1-805.
    • IARC Sci Publ , vol.1986 , pp. 1-805
    • Muir, C.S.1    Wagner, G.2    Demaret, E.3
  • 21
    • 3142708548 scopus 로고    scopus 로고
    • Pharmacokinetic advantage of intra-arterial hepatic oxaliplatin administration: Comparative results with cisplatin using a rabbit VX2 tumor model
    • Dzodic R, Gomez-Abuin G, Rougier P, et al.: Pharmacokinetic advantage of intra-arterial hepatic oxaliplatin administration: Comparative results with cisplatin using a rabbit VX2 tumor model. Anticancer Drugs 2004; 15: 647-650.
    • (2004) Anticancer Drugs , vol.15 , pp. 647-650
    • Dzodic, R.1    Gomez-Abuin, G.2    Rougier, P.3
  • 22
    • 24644443860 scopus 로고    scopus 로고
    • Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: A trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer
    • Ducreux M, Ychou M, Laplanche A, et al.: Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: A trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer. J Clin Oncol 2005; 23: 4881-4887.
    • (2005) J Clin Oncol , vol.23 , pp. 4881-4887
    • Ducreux, M.1    Ychou, M.2    Laplanche, A.3
  • 23
    • 0942266283 scopus 로고    scopus 로고
    • Continuous infusion of hepatic arterial irinotecan in pretreated patients with colorectal cancer metastatic to the liver
    • van Riel JMGH, van Groeningen CJ, de Greve J, et al.: Continuous infusion of hepatic arterial irinotecan in pretreated patients with colorectal cancer metastatic to the liver. Ann Oncol 2004; 15: 59-63.
    • (2004) Ann Oncol , vol.15 , pp. 59-63
    • Van Riel, J.1    Van Groeningen, C.J.2    De Greve, J.3
  • 24
    • 0022374107 scopus 로고
    • A reversible enteropathy complicating continuous hepatic artery infusion chemotherapy with 5-fluoro-2-deoxyuridine
    • Gluck WL, Akwari OE, Kelvin FM, et al.: A reversible enteropathy complicating continuous hepatic artery infusion chemotherapy with 5-fluoro-2-deoxyuridine. Cancer 1985; 56: 2424-2427.
    • (1985) Cancer , vol.56 , pp. 2424-2427
    • Gluck, W.L.1    Akwari, O.E.2    Kelvin, F.M.3
  • 25
    • 0018774418 scopus 로고
    • A new look at the arterial supply of the bile duct in man and its surgical implications
    • Northover JM, Terblanche J,: A new look at the arterial supply of the bile duct in man and its surgical implications. Br J Surg 1979; 66: 379-384.
    • (1979) Br J Surg , vol.66 , pp. 379-384
    • Northover, J.M.1    Terblanche, J.2
  • 26
    • 0036844353 scopus 로고    scopus 로고
    • Hepatic artery chemotherapy for colorectal liver metastases: Technical considerations and review of clinical trials
    • Skitzki J, Chang A,: Hepatic artery chemotherapy for colorectal liver metastases: Technical considerations and review of clinical trials. Surg Oncol 2002; 11: 123-135.
    • (2002) Surg Oncol , vol.11 , pp. 123-135
    • Skitzki, J.1    Chang, A.2
  • 27
    • 0021592866 scopus 로고
    • Hepatic artery pump infusion: Toxicity and results in patients with metastatic colorectal carcinoma
    • Kemeny N, Daly J, Oderman P, et al.: Hepatic artery pump infusion: Toxicity and results in patients with metastatic colorectal carcinoma. J Clin Oncol 1984; 2: 595-600.
    • (1984) J Clin Oncol , vol.2 , pp. 595-600
    • Kemeny, N.1    Daly, J.2    Oderman, P.3
  • 28
    • 0026570019 scopus 로고
    • A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer
    • Kemeny N, Seiter K, Niedzwiecki D, et al.: A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer. Cancer 1992; 69: 327-334.
    • (1992) Cancer , vol.69 , pp. 327-334
    • Kemeny, N.1    Seiter, K.2    Niedzwiecki, D.3
  • 29
    • 0030249457 scopus 로고    scopus 로고
    • Alternating floxuridine and 5-fluorouracil hepatic arterial chemotherapy for colorectal liver metastases minimizes biliary toxicity
    • Davidson BS, Izzo F, Chase JL, et al.: Alternating floxuridine and 5-fluorouracil hepatic arterial chemotherapy for colorectal liver metastases minimizes biliary toxicity. Am J Surg 1996; 172: 244-247.
    • (1996) Am J Surg , vol.172 , pp. 244-247
    • Davidson, B.S.1    Izzo, F.2    Chase, J.L.3
  • 30
    • 0026016624 scopus 로고
    • Alternating hepatic intra-arterial floxuridine and fluorouracil: A less toxic regimen for treatment of liver metastases from colorectal cancer
    • Stagg RJ, Venook AP, Chase JL, et al.: Alternating hepatic intra-arterial floxuridine and fluorouracil: A less toxic regimen for treatment of liver metastases from colorectal cancer. J Natl Cancer Inst 1991; 83: 423-428.
    • (1991) J Natl Cancer Inst , vol.83 , pp. 423-428
    • Stagg, R.J.1    Venook, A.P.2    Chase, J.L.3
  • 31
    • 70249149719 scopus 로고    scopus 로고
    • Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma
    • Kemeny N, Melendez FDH, Capanu M, et al.: Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma. J Clin Oncol 2009; 27: 3465-3471.
    • (2009) J Clin Oncol , vol.27 , pp. 3465-3471
    • Kemeny, N.1    Melendez, F.D.H.2    Capanu, M.3
  • 32
    • 0345505228 scopus 로고    scopus 로고
    • Patterns of failure following curative resection of colorectal liver metastases
    • Topal B, Kaufman L, Aerts R, et al.: Patterns of failure following curative resection of colorectal liver metastases. Eur J Surg Oncol 2003; 29: 248-253.
    • (2003) Eur J Surg Oncol , vol.29 , pp. 248-253
    • Topal, B.1    Kaufman, L.2    Aerts, R.3
  • 33
    • 0035108283 scopus 로고    scopus 로고
    • Repeat hepatectomy for colorectal liver metastases: A worthwhile operation?
    • Muratore A, Polastri R, Bouzari H, et al.: Repeat hepatectomy for colorectal liver metastases: A worthwhile operation? J Surg Oncol 2001; 76: 127-132.
    • (2001) J Surg Oncol , vol.76 , pp. 127-132
    • Muratore, A.1    Polastri, R.2    Bouzari, H.3
  • 34
    • 0029010380 scopus 로고
    • Resection versus resection combined with adjuvant pre- and post-operative chemotherapy-immunotherapy for metastatic colorectal liver cancer. A new look at an old problem
    • Lygidakis NJ, Ziras N, Parissis J,: Resection versus resection combined with adjuvant pre- and post-operative chemotherapy-immunotherapy for metastatic colorectal liver cancer. A new look at an old problem. Hepatogastroenterology 1995; 42: 155-161.
    • (1995) Hepatogastroenterology , vol.42 , pp. 155-161
    • Lygidakis, N.J.1    Ziras, N.2    Parissis, J.3
  • 35
    • 0035658785 scopus 로고    scopus 로고
    • Metastatic liver disease of colorectal origin: The value of locoregional immunochemotherapy combined with systemic chemotherapy following liver resection. Results of a prospective randomized study
    • Lygidakis NJ, Sgourakis G, Vlachos L, et al.: Metastatic liver disease of colorectal origin: The value of locoregional immunochemotherapy combined with systemic chemotherapy following liver resection. Results of a prospective randomized study. Hepatogastroenterology 2001; 48: 1685-1691.
    • (2001) Hepatogastroenterology , vol.48 , pp. 1685-1691
    • Lygidakis, N.J.1    Sgourakis, G.2    Vlachos, L.3
  • 36
    • 13744255337 scopus 로고    scopus 로고
    • Hepatic arterial infusion after liver resection
    • Kemeny NE, Gonen M,: Hepatic arterial infusion after liver resection. N Engl J Med 2005; 352: 734-735.
    • (2005) N Engl J Med , vol.352 , pp. 734-735
    • Kemeny, N.E.1    Gonen, M.2
  • 37
    • 0037087721 scopus 로고    scopus 로고
    • Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: Surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy-An intergroup study
    • Kemeny MM, Adak S, Gray B, et al.: Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: Surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy-An intergroup study. J Clin Oncol 2002; 20: 1499-1505.
    • (2002) J Clin Oncol , vol.20 , pp. 1499-1505
    • Kemeny, M.M.1    Adak, S.2    Gray, B.3
  • 38
    • 0343729320 scopus 로고    scopus 로고
    • Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German Cooperative on Liver Metastases (Arbeitsgruppe Lebermetastasen)
    • Lorenz M, Muller HH, Schramm H, et al.: Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German Cooperative on Liver Metastases (Arbeitsgruppe Lebermetastasen). Ann Surg 1998; 228: 756-762.
    • (1998) Ann Surg , vol.228 , pp. 756-762
    • Lorenz, M.1    Muller, H.H.2    Schramm, H.3
  • 39
    • 35648981122 scopus 로고    scopus 로고
    • Actual 10-year survival after resection of colorectal liver metastases defines cure
    • Tomlinson JS, Jarnagin WR, DeMatteo RP, et al.: Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol 2007; 25: 4575-4580.
    • (2007) J Clin Oncol , vol.25 , pp. 4575-4580
    • Tomlinson, J.S.1    Jarnagin, W.R.2    Dematteo, R.P.3
  • 41
    • 77952324326 scopus 로고    scopus 로고
    • Comparison of adjuvant systemic chemotherapy with or without hepatic arterial infusional chemotherapy after hepatic resection for metastatic colorectal cancer
    • House MG, Kemeny N, Jarnagin W, et al.: Comparison of adjuvant systemic chemotherapy with or without hepatic arterial infusional chemotherapy after hepatic resection for metastatic colorectal cancer. American Society of Clinical Oncology 2009 Gastrointestinal Cancers Symposium, 2009.
    • (2009) American Society of Clinical Oncology 2009 Gastrointestinal Cancers Symposium
    • House, M.G.1    Kemeny, N.2    Jarnagin, W.3
  • 42
    • 0141799961 scopus 로고    scopus 로고
    • Phase I/II study of hepatic arterial therapy with floxuridine and dexamethasone in combination with intravenous irinotecan as adjuvant treatment after resection of hepatic metastases from colorectal cancer
    • Kemeny N, Jarnagin W, Gonen M, et al.: Phase I/II study of hepatic arterial therapy with floxuridine and dexamethasone in combination with intravenous irinotecan as adjuvant treatment after resection of hepatic metastases from colorectal cancer. J Clin Oncol 2003; 21: 3303-3309.
    • (2003) J Clin Oncol , vol.21 , pp. 3303-3309
    • Kemeny, N.1    Jarnagin, W.2    Gonen, M.3
  • 43
    • 67650354362 scopus 로고    scopus 로고
    • Phase i trial of adjuvant hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone plus systemic oxaliplatin, 5-fluorouracil and leucovorin in patients with resected liver metastases from colorectal cancer
    • Kemeny N, Capanu M, D'Angelica M, et al.: Phase I trial of adjuvant hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone plus systemic oxaliplatin, 5-fluorouracil and leucovorin in patients with resected liver metastases from colorectal cancer. Ann Oncol 2009; 20: 1236-1241.
    • (2009) Ann Oncol , vol.20 , pp. 1236-1241
    • Kemeny, N.1    Capanu, M.2    D'Angelica, M.3
  • 44
    • 35348905517 scopus 로고    scopus 로고
    • Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases
    • Barone C, Nuzzo G, Cassano A, et al.: Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases. Br J Cancer 2007; 97: 1035-1039.
    • (2007) Br J Cancer , vol.97 , pp. 1035-1039
    • Barone, C.1    Nuzzo, G.2    Cassano, A.3
  • 45
    • 36749067866 scopus 로고    scopus 로고
    • Phase II trial of cetuximab in combination with fluorouracil, leucovorin, and oxaliplatin in the first-line treatment of metastatic colorectal cancer
    • Tabernero J, Van Cutsem E, Diaz-Rubio E, et al.: Phase II trial of cetuximab in combination with fluorouracil, leucovorin, and oxaliplatin in the first-line treatment of metastatic colorectal cancer. J Clin Oncol 2007; 25: 5225-5232.
    • (2007) J Clin Oncol , vol.25 , pp. 5225-5232
    • Tabernero, J.1    Van Cutsem, E.2    Diaz-Rubio, E.3
  • 46
    • 37349026722 scopus 로고    scopus 로고
    • Hepatic arterial infusion plus systemic irinotecan in patients with unresectable hepatic metastases from colorectal cancer previously treated with systemic oxaliplatin: A retrospective analysis
    • Gallagher DJ, Capanu M, Raggio G, et al.: Hepatic arterial infusion plus systemic irinotecan in patients with unresectable hepatic metastases from colorectal cancer previously treated with systemic oxaliplatin: A retrospective analysis. Ann Oncol 2007; 18: 1995-1999.
    • (2007) Ann Oncol , vol.18 , pp. 1995-1999
    • Gallagher, D.J.1    Capanu, M.2    Raggio, G.3
  • 47
    • 38049164083 scopus 로고    scopus 로고
    • Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure
    • Boige V, Malka D, Elias D, et al.: Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure. Ann Surg Oncol 2008; 15: 219-226.
    • (2008) Ann Surg Oncol , vol.15 , pp. 219-226
    • Boige, V.1    Malka, D.2    Elias, D.3
  • 48
    • 0023552654 scopus 로고
    • A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases
    • Chang AE, Schneider PD, Sugarbaker PH, et al.: A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg 1987; 206: 685-693.
    • (1987) Ann Surg , vol.206 , pp. 685-693
    • Chang, A.E.1    Schneider, P.D.2    Sugarbaker, P.H.3
  • 49
    • 0023191990 scopus 로고
    • Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial
    • Kemeny N, Daly J, Reichman B, et al.: Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial. Ann Intern Med 1987; 107: 459-465. (Pubitemid 17149758)
    • (1987) Annals of Internal Medicine , vol.107 , Issue.4 , pp. 459-465
    • Kemeny, N.1    Daly, J.2    Reichman, B.3    Geller, N.4    Botet, J.5    Oderman, P.6
  • 50
    • 0024425297 scopus 로고
    • A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: The Northern California Oncology Group trial
    • Hohn DC, Stagg RJ, Friedman MA, et al.: A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: The Northern California Oncology Group trial. J Clin Oncol 1989; 7: 1646-1654.
    • (1989) J Clin Oncol , vol.7 , pp. 1646-1654
    • Hohn, D.C.1    Stagg, R.J.2    Friedman, M.A.3
  • 51
    • 0026625223 scopus 로고
    • Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: Long-term results of a prospective randomized trial
    • Rougier P, Laplanche A, Huguier M, et al.: Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: Long-term results of a prospective randomized trial. J Clin Oncol 1992; 10: 1112-1118.
    • (1992) J Clin Oncol , vol.10 , pp. 1112-1118
    • Rougier, P.1    Laplanche, A.2    Huguier, M.3
  • 52
    • 0028150629 scopus 로고
    • Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases
    • Allen-Mersh TG, Earlam S, Fordy C, et al.: Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases. Lancet 1994; 344: 1255-1260.
    • (1994) Lancet , vol.344 , pp. 1255-1260
    • Allen-Mersh, T.G.1    Earlam, S.2    Fordy, C.3
  • 53
    • 0343048340 scopus 로고    scopus 로고
    • Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma
    • Lorenz M, Muller HH,: Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma. J Clin Oncol 2000; 18: 243-254.
    • (2000) J Clin Oncol , vol.18 , pp. 243-254
    • Lorenz, M.1    Muller, H.H.2
  • 54
    • 0037308489 scopus 로고    scopus 로고
    • Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: A multicentre randomised trial
    • Kerr DJ, McArdle CS, Ledermann J, et al.: Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: A multicentre randomised trial. Lancet 2003; 361: 368-373.
    • (2003) Lancet , vol.361 , pp. 368-373
    • Kerr, D.J.1    McArdle, C.S.2    Ledermann, J.3
  • 55
    • 33645450153 scopus 로고    scopus 로고
    • Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: A randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481)
    • Kemeny NE, Niedzwiecki D, Hollis DR, et al.: Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: A randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481). J Clin Oncol 2006; 24: 1395-1403.
    • (2006) J Clin Oncol , vol.24 , pp. 1395-1403
    • Kemeny, N.E.1    Niedzwiecki, D.2    Hollis, D.R.3
  • 56
    • 1342290189 scopus 로고    scopus 로고
    • FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: A randomized GERCOR study
    • Tournigand C, Andr T, Achille E, et al.: FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: A randomized GERCOR study. J Clin Oncol 2004; 22: 229-237.
    • (2004) J Clin Oncol , vol.22 , pp. 229-237
    • Tournigand, C.1    Andr, T.2    Achille, E.3
  • 57
    • 2542561964 scopus 로고    scopus 로고
    • Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
    • Hurwitz H, Fehrenbacher L, Novotny W, et al.: Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004; 350: 2335-2342.
    • (2004) N Engl J Med , vol.350 , pp. 2335-2342
    • Hurwitz, H.1    Fehrenbacher, L.2    Novotny, W.3
  • 58
    • 33846055070 scopus 로고    scopus 로고
    • Hepatic arterial chemotherapy in combination with systemic chemotherapy compared with hepatic arterial chemotherapy alone for liver metastases from colorectal cancer: Results of a multi-centric randomized study
    • Fiorentini G, Cantore M, Rossi S, et al.: Hepatic arterial chemotherapy in combination with systemic chemotherapy compared with hepatic arterial chemotherapy alone for liver metastases from colorectal cancer: Results of a multi-centric randomized study. In Vivo 2006; 20: 707-709.
    • (2006) Vivo , vol.20 , pp. 707-709
    • Fiorentini, G.1    Cantore, M.2    Rossi, S.3
  • 59
    • 53049092394 scopus 로고    scopus 로고
    • Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: A randomized phase III noninferiority study
    • Rothenberg ML, Cox JV, Butts C, et al.: Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: A randomized phase III noninferiority study. Ann Oncol 2008; 19: 1720-1726.
    • (2008) Ann Oncol , vol.19 , pp. 1720-1726
    • Rothenberg, M.L.1    Cox, J.V.2    Butts, C.3
  • 60
    • 24644484863 scopus 로고    scopus 로고
    • Phase i trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer
    • Kemeny N, Jarnagin W, Paty P, et al.: Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer. J Clin Oncol 2005; 23: 4888-4896.
    • (2005) J Clin Oncol , vol.23 , pp. 4888-4896
    • Kemeny, N.1    Jarnagin, W.2    Paty, P.3
  • 61
    • 0035873927 scopus 로고    scopus 로고
    • Phase i study of hepatic arterial infusion of floxuridine and dexamethasone with systemic irinotecan for unresectable hepatic metastases from colorectal cancer
    • Kemeny N, Gonen M, Sullivan D, et al.: Phase I study of hepatic arterial infusion of floxuridine and dexamethasone with systemic irinotecan for unresectable hepatic metastases from colorectal cancer. J Clin Oncol 2001; 19: 2687-2695.
    • (2001) J Clin Oncol , vol.19 , pp. 2687-2695
    • Kemeny, N.1    Gonen, M.2    Sullivan, D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.